News

Home/News
News 2017-06-21T13:15:59+00:00
March 8, 2018
VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma
TEL AVIV, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), today reported top-line results from its pivotal Phase 3 GLOBE study in patients ...
March 8, 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
NEW YORK and PETACH TIKVAH, Israel, March 8, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
March 8, 2018
Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018
SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage biotechnology company developing first-in-class agents that target the ...
March 8, 2018
Innate Pharma Hosts R&D Day Today in London
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer, will today outline development ...
March 8, 2018
UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018
RA’ANANA, Israel and NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN) today announced that it will report fourth quarter and full ...
March 8, 2018
Gemphire to Present at Two Investor Conferences
LIVONIA, Mich., March 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
March 8, 2018
Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018
REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
March 8, 2018
Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase
AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
March 8, 2018
Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2017 Financial Results and Provide Corporate Update on Wednesday, March 14
SAN DIEGO, March 8, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), will announce its fourth quarter and full-year 2017 financial results on Wednesday, March 14, 2018, ...
March 8, 2018
Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (CKPT), a Fortress Biotech (FBIO) company, today announced the pricing ...
March 7, 2018
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
EMERYVILLE, Calif., March 06, 2018 (GLOBE NEWSWIRE) --  Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
March 7, 2018
Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
March 7, 2018
TherapeuticsMD to Present at Two Upcoming Investor Conferences
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that the Company will participate in the Cowen and Company 38th Annual ...
March 7, 2018
STRATA Skin Sciences, Inc. Delays Fourth Quarter and Fiscal 2017 Financial Results
HORSHAM, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
March 7, 2018
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics that target the underlying ...
March 7, 2018
BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2017 Financial Results on Thursday, March 15
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
March 7, 2018
Catalyst Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 7, 2018
Aimmune Therapeutics to Participate in Four Investor Conferences in March
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of the Aimmune executive management team ...
March 7, 2018
BioCanCell Announces Two New Key Hires in Clinical Development and Clinical Operations
CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies ...
March 7, 2018
BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, today announced that the independent Data Safety Monitoring Board ...
Page 13 of 70